Evidence map›Paper›PMID 28932896›Full record

ReviewDer Nervenarzt2018

[Update on anti-N-methyl-D-aspartate receptor encephalitis].

S Kovac, J Alferink, D Ahmetspahic, V Arolt, N Melzer

Abstract readReview
PubMed Publisher
In one paragraph

Review in Der Nervenarzt, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

S KovacKlinik für Allgemeine Neurologie mit Institut für Translationale Neurologie, Universitätsklinikum Münster, Albert-Schweitzer-Campus 1, 48149, Münster, Deutschland.
J AlferinkCluster of Excellence EXC 1003, Cells in Motion, Universität Münster, Münster, Deutschland.
D AhmetspahicCluster of Excellence EXC 1003, Cells in Motion, Universität Münster, Münster, Deutschland.
V AroltCluster of Excellence EXC 1003, Cells in Motion, Universität Münster, Münster, Deutschland.
N MelzerKlinik für Allgemeine Neurologie mit Institut für Translationale Neurologie, Universitätsklinikum Münster, Albert-Schweitzer-Campus 1, 48149, Münster, Deutschland. nico.melzer@ukmuenster.de.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Autoimmune encephalitis is a group of autoimmune inflammatory disorders affecting both grey and white matter of the central nervous system. Encephalitis with autoantibodies against the N‑methyl-D-aspartate receptor (NMDA-R) is the most frequent autoimmune encephalitis syndrome presenting with a characteristic sequence of psychiatric and neurological symptoms. Treatment necessitates a close interdisciplinary cooperation. This article provides an update on the current knowledge on diagnostic standards, pathogenesis, and treatment strategies for anti-NMDA-R encephalitis from psychiatric and neurological perspectives.

Indexed as

Anti-N-Methyl-D-Aspartate Receptor EncephalitisAutoantibodiesCognition DisordersDiagnosis, DifferentialFemaleHumansInterdisciplinary CommunicationIntersectoral CollaborationMaleMental DisordersNeuralgia, PostherpeticOvarian NeoplasmsParaneoplastic SyndromesPrognosisReceptors, N-Methyl-D-AspartateTeratomaAutoantibodiesReceptors, N-Methyl-D-AspartateAutoantibody-mediated encephalitisHerpes simplex encephalitisNeurological symptomsOvarian teratomaPsychiatric symptoms

Identifiers

PMID28932896

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.